Skip to main content

Table 1 Clinical characteristics of the allo-HSCT patients

From: Serum proteomic profiling and haptoglobin polymorphisms in patients with GVHD after allogeneic hematopoietic cell transplantation

 

Sex/Age

Diagnosis

GVHD

Grade

Organ involvement

Conditioning Regimen

GVHD Prophylaxis

Infections

Outcome

1.*

F/40

AML

Chronic

Extensive

Skin eye oral

Cy/TBI/ATG

Tac/MTX

None

Alive, no active GVHD

2.*

M/28

CML

Chronic

Extensive

Liver

Bu/Cy

Tac/MTX

None

Alive, no active GVHD

3.

M/48

AML

Chronic

Extensive

Skin eyes oral gut

Bu/Cy

Tac/MTX

None

Alive, active GVHD

4.*

F/42

AML

Chronic

Extensive

Skin eye oral

Cy/TBI

Tac/MTX

None

Dead, AML relapse

5.*

F/42

IMF

Chronic

Extensive

Skin oral eye liver

Bu/Cy

Tac/MTX

None

Alive, active GVHD

6.

M/49

CLL

Chronic

Limited

Skin eye oral

Cy/TBI

Tac/MTX

None

Dead, GVHD

7.*

F/29

CML

Chronic

Extensive

Skin Gut

Cy/TBI

CSA/MTX

CMV

Dead, CMV pneumonia

8.*

F/58

AML

Chronic

Extensive

Skin Gut

Cy/TBI

CSA/MTX

None

Dead, unknown causes

9.*

F/45

AML

Chronic

Extensive

Skin

Cy/TBI

CSA/MTX

CMV

Dead, CMV/organ failure

10.*

M/38

CML

Chronic

Extensive

Eye oral gut

Bu/Cy

Tac/MTX

None

Alive, active GVHD

11.*

F/54

SAA

Chronic

Limited

Skin, oral

Cy/TBI/ATG

Tac/MTX

None

Alive, no active GVHD

12.*

M/54

NHL

Chronic

Extensive

Skin eye

Cy/TBI

Tac/MTX

None

Alive, active GVHD

13.

M/54

NHL

Chronic

Limited

Oral

BEAC

Tac/MTX

None

Alive, no active GVHD

14.*

M/50

NHL

Chronic

Extensive

Skin, lung

Cy/TBI/ATG

Tac/MTX

None

Dead, GVHD

15.

M/59

AML

Chronic

Limited

Skin Gut

Bu/Cy

Tac/MTX

CMV

Alive, active GVHD

16.

M/52

NHL

Chronic

Extensive

Skin Gut Oral

Cy/TBI/ATG

Tac/MTX

CMV

Alive, active GVHD

17.

M/29

CML

No GVHD

-

-

Cy/TBI

Tac/MTX

None

Alive, no active GVHD

18.

M/61

CLL

No GVHD

-

-

Bu/Flu/ATG

Tac/MTX

None

Alive, no active GVHD

19.*

F/40

AML

No GVHD

-

-

Cy/TBI/ATG

Tac/MTX

CMV, EBV

Alive, no active GVHD

20.

F/58

MDS

No GVHD

-

-

Cy/TBI

Tac/MTX

None

Dead, AML/MDS relapsed

21.*

M/38

AML

No GVHD

-

-

Cy/TBI/ATG

Tac/MTX

None

Dead, relapsed

22.

M/23

AML

No GVHD

-

-

Cy/TBI/ATG

Tac/MTX

None

Alive, no active GVHD

23.*

F/49

AML

No GVHD

-

-

Cy/TBI/ATG

Tac/MTX

None

Alive, no active GVHD

24.*

M/31

CML

No GVHD

-

-

Bu/Cy/ATG

Tac/MTX

None

Alive, no active GVHD

25.*

F/54

NHL

No GVHD

-

-

Cy/TBI/ATG

Tac/MTX

None

Dead, heart failure

  1. AML: acute myelogenous leukemia; CML: chronic myelogenous leukemia; IMF: idiopathic myelofibrosis; CLL: chronic lymphocyte leukemia: SAA: severe aplastic anemia; NHL: Non-Hodgkin's Lymphoma; ALL: acute lymphoblastic leukemia; MM: multiple myeloma; MDS: myelodysplastic syndrome; * done of 2-DE gel assay.